Enhertu.com
Visit enhertu.com-
1K
Daily Visitors
-
1 month ago
Last scanned
-
6 years
Domain Age
-
No data
Global Rank
Enhertu.com
Visit enhertu.com
About Website
Updated:
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Official Patient Website
Learn more about ENHERTU® (fam-trastuzumab deruxtecan-nxki) for several types of cancer. See Full Safety and Boxed WARNINGS for more information.
Network Data
This website is hosted with Microsoft Corporation, which reserves the following IP addresses for enhertu.com: 40.118.104.64. Moreover, DNS used with this website include ns1.markmonitor.com, ns2.markmonitor.com, ns3.markmonitor.com, ns4.markmonitor.com, ns5.markmonitor.com, ns6.markmonitor.com, ns7.markmonitor.com. Subnet identifier ranges from 20.33.0.0 to 20.128.255.255. Classless Inter-Domain Routing (CIDR) is 20.34.0.0/15, 20.48.0.0/12, 20.64.0.0/10, 20.33.0.0/16, 20.128.0.0/16, 20.40.0.0/13, 20.36.0.0/14. ARIN net type is Direct Allocation.
-
1K
Daily Visitors
-
1 month ago
Last scanned
-
6 years
Domain Age
-
No data
Global Rank
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns1.markmonitor.com
ns2.markmonitor.com
ns3.markmonitor.com
ns4.markmonitor.com
ns5.markmonitor.com
ns6.markmonitor.com
ns7.markmonitor.com
Whois
OWNERSHIP
-
Created
2017-11-06
-
Expires
2025-11-05
-
Owner
-
Registar
MarkMonitor Inc.
Domain & Keywords
The registrar of enhertu.com is MarkMonitor Inc. and the name expires on 2025-11-05. Owner email is not available. Their country of residence is Japan.